Multielectrode array characterization of human induced pluripotent stem cell derived neurons in co-culture with primary human astrocytes

Maddie R. Lemieux,Bernhard Freigassner,Zahra Thathey,Mark R. Opp,Charles A Hoeffer,Christopher D. Link

DOI: https://doi.org/10.1101/2024.03.04.583341

2024-03-08

Abstract:Human induced pluripotent stem cells (hiPSCs) derived into neurons offer a powerful model to study cellular processes. One method to characterize functional network properties of these cells is using multielectrode arrays (MEAs). MEAs can measure the electrophysiological activity of cellular cultures for extended periods of time without disruption. Here we used WTC11 hiPSCs with a doxycycline-inducible neurogenin 2 (NGN2) transgene differentiated into neurons co-cultured with primary human astrocytes. We achieved a synchrony index ∼0.9 in as little as six-weeks with a mean firing rate of ∼13 Hz. Previous reports show that derived 3D brain organoids can take several months to achieve similar strong network burst synchrony. We also used this co-culture to model aspects of sporadic Alzheimer’s disease by mimicking blood-brain barrier breakdown using a human serum. Our fully human co-culture achieved strong network burst synchrony in a fraction of the time of previous reports, making it an excellent first pass, high-throughput method for studying network properties and neurodegenerative diseases.

Neuroscience

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects:

1. **Accelerating the Maturation of Human Neural Networks**: Researchers use multi - electrode array (MEA) technology. By co - culturing neurons differentiated from induced pluripotent stem cells (iPSCs) with primary human astrocytes, they aim to accelerate the time for the neural network to reach strong synchronous bursts. In traditional methods, it takes months for human neural networks to reach a similar highly synchronous state, while this research achieved this goal within just six weeks. This provides a fast and effective model for high - throughput research on neural network characteristics and neurodegenerative diseases.

2. **Simulating Sporadic Alzheimer's Disease**: The research also uses this co - culture system to simulate the blood - brain barrier breakdown phenomenon in sporadic Alzheimer's disease (AD). By adding 10% human serum to the culture, simulating the situation of blood - brain barrier breakage, a significant decrease in neuronal activity was observed. The synchronization index dropped from the baseline average of 0.88 to 0.01, and there was almost no network burst activity. These results indicate that this model can be used to study the pathological mechanisms of AD and its potential treatment strategies.

3. **Verifying the Functionality of Neural Networks**: To confirm the validity of the established neural network model, researchers carried out pharmacological verification experiments. By using glutamate receptor inhibitors (such as CNQX and AP5), researchers found that these inhibitors could significantly reduce the firing rate of neurons and completely inhibit network bursts, confirming the crucial role of glutamatergic neurons in this synchronous network. In addition, γ - aminobutyric acid (GABA) receptor inhibitors (such as bicuculline) have little impact on network activity, further supporting the view that this model is mainly driven by glutamatergic neurons.

In conclusion, the main purpose of this paper is to develop an efficient and rapid method for studying the characteristics of human neural networks and their changes in neurodegenerative diseases, especially by shortening the maturation time of neural networks to improve research efficiency and accuracy.